Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11276 - 11300 of 12647 in total
Fosravuconazole is under investigation in clinical trial NCT03378661 (BENDITA BEnznidazole New Doses Improved Treatment and Associations).
Investigational
Matched Iupac: … ({[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan ... -2-yl]oxy}methoxy)phosphonic acid …
BMS-754807 is under investigation in clinical trial NCT00908024 (Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors).
Investigational
Matched Iupac: … (2S)-1-{4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl}-N-(6-fluoropyridin ... -3-yl)-2-methylpyrrolidine-2-carboxamide …
Investigational
Matched Iupac: … N-{5-cyano-4-[(2-methoxyethyl)amino]pyridin-2-yl}-7-formyl-6-[(4-methyl-2-oxopiperazin-1-yl)methyl]-1,2,3,4 …
Fimasartan is an angiotensin II receptor antagonist (ARB) drug employed in the treatment of both hypertension and heart failure. It has been found to be safe when administered with hydrochlorothiazide (a diuretic) in clinical trials. Fimasartan was initially approved September 9th, 2010 in South Korea and is marketed under the...
Investigational
Matched Iupac: … 2-(2-butyl-4-methyl-6-oxo-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1,6-dihydropyrimidin ... -5-yl)-N,N-dimethylethanethioamide …
Experimental
Matched Iupac: … (2R)-2-(phosphonooxy)propanoic acid …
Experimental
Matched Iupac: … (2R)-4-methylpentan-2-amine …
Experimental
Matched Iupac: … 2-(3-carboxypropanoyl)benzoic acid …
Experimental
Matched Iupac: … 2-(carboxyformamido)-5-iodobenzoic acid …
Experimental
Matched Iupac: … (benzyloxy)(2-formylphenoxy)phosphinic acid …
Experimental
Matched Iupac: … (2R)-2-(phenylformamido)propanoic acid …
Pheniprazine is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class that was used as an antidepressant in the 1960s. In addition, it was used for the treatment of other conditions, such as angina pectoris and schizophrenia. Pheniprazine was withdrawn by its manufacturer due to its...
Withdrawn
Matched Iupac: … (1-phenylpropan-2-yl)hydrazine …
Tacedinaline has been used in trials studying the treatment of Lung Cancer, Multiple Myeloma, and Pancreatic Cancer.
Investigational
Matched Iupac: … N-(2-aminophenyl)-4-acetamidobenzamide …
Experimental
Matched Iupac: … (4,4-diphenylbutan-2-yl)dimethylamine …
Experimental
Matched Iupac: … (2-bromo-3-methylbutanoyl)urea …
Experimental
Matched Iupac: … 2-(1-hydroxycyclohexyl)butanoic acid …
Experimental
Matched Iupac: … [2-(1,2-diphenylethoxy)ethyl]trimethylazanium …
Experimental
Matched Iupac: … 3-[(2Z)-2-[(5-{[(2Z,5Z)-5-{[3-(2-carboxyethyl)-4-methyl-2-oxo-2H-pyrrol-5-yl]methylidene}-4-ethenyl-3 ... -methyl-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-ethenyl-3-methyl-1H-pyrrol-2-yl)methylidene]-5-hydroxy ... -3-methyl-2H-pyrrol-4-yl]propanoic acid …
Experimental
Matched Iupac: … 2-oxo-3-sulfopropanoic acid …
Experimental
Matched Iupac: … 2-[(diaminomethylidene)amino]acetic acid …
Matched Salts cas: … 81129-50-2
Experimental
Matched Iupac: … (2S)-1-phenylbutan-2-amine …
Experimental
Matched Iupac: … (propan-2-yloxy)phosphonic acid …
Experimental
Matched Iupac: … 2-[(cyclohexylcarbamoyl)amino]acetic acid …
Phenoxypropazine is a non-selective and irreversible monoamine oxidase enzyme inhibitor (MAOI), belonging to the hydrazine chemical class. It was marketed as an antidepressant in 1961 but was later withdrawn in 1966 because of its hepatotoxic potential.
Withdrawn
Matched Iupac: … (1-phenoxypropan-2-yl)hydrazine …
Experimental
Matched Iupac: … (2R)-2-acetamido-3-sulfanylpropanamide …
Investigational
Matched Iupac: … dodecyl 2-(N-methylcarbamimidamido)acetate …
Displaying drugs 11276 - 11300 of 12647 in total